A FTIH Study With GSK3008348 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
Phase of Trial: Phase I
Latest Information Update: 04 May 2017
At a glance
- Drugs GSK 3008348 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; First in man
- Sponsors GlaxoSmithKline
- 06 Jul 2016 Status changed from recruiting to completed.
- 12 Jan 2016 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 18 Dec 2015 Planned initiation date changed from 1 Nov 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.